• Title/Summary/Keyword: Response to radiation

Search Result 1,261, Processing Time 0.027 seconds

A Review of Dose Rate Meters as First Responders to Ionising Radiation

  • Akber, Aqeel Ahmad;Wiggins, Matthew Benfield
    • Journal of Radiation Protection and Research
    • /
    • v.44 no.3
    • /
    • pp.97-102
    • /
    • 2019
  • Background: Dose rate meters are the most widely used, and perhaps one of the most important tools for the measurement of ionising radiation. They are often the first, or only, device available to a user for an instant check of radiation dose at a certain location. Throughout the world, radiation safety practices rely strongly on the output of these dose rate meters. But how well do we know the quality of their output? Materials and Methods: This review is based on the measurements 1,158 commercially available dose rate meters of 116 different makes and models. Expected versus the displayed dose patterns and consistency was checked at various dose rates between $5{\mu}Gy{\cdot}h^{-1}$ and $2mGy{\cdot}h^{-1}$. Samples of these meters were then selected for further investigation and were exposed to radiation sources covering photon energies from 50 keV to 1.5 MeV. The effect of detector orientation on its reading was also investigated. Rather than focusing on the angular response distribution that is often reported by the manufacturer of the device, this study focussed on the design ergonomics i.e. the angles that the operator will realistically use to measure a dose rate. Results and Discussion: This review shows the scope and boundaries of the ionising radiation dose rate estimations that are made using commonly available meters. Observations showed both inter and intra make and model variations, occasional cases of instrument failure, instrument walk away, and erroneous response. Conclusion: The results indicate the significance of selecting and maintaining suitable monitors for specific applications in radiation safety.

Single nucleotide polymorphism of GSTP1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy

  • Nicosia, Luca;Gentile, Giovanna;Reverberi, Chiara;Minniti, Giuseppe;Valeriani, Maurizio;de Sanctis, Vitaliana;Marinelli, Luca;Cipolla, Fabiola;de Luca, Ottavia;Simmaco, Maurizio;Osti, Mattia F.
    • Radiation Oncology Journal
    • /
    • v.36 no.3
    • /
    • pp.218-226
    • /
    • 2018
  • Purpose: Standard treatment for locally advanced rectal cancer consists of neoadjuvant radiochemotherapy with concomitant fluoropyrimidine or oxaliplatin and surgery with curative intent. Pathological complete response has shown to be predictive for better outcome and survival; nevertheless there are no biological or genetic factors predictive for response to treatment. We explored the correlation between the single nucleotide polymorphisms (SNPs) GSTP1 (A313G) and XRCC1 (G28152A), and the pathological complete response and survival after neoadjuvant radiochemotherapy in locally advanced rectal cancer patients. Materials and Methods: Genotypes GSTP1 (A313G) and XRCC1 (G28152A) were determined by pyrosequencing technology in 80 patients affected by locally advanced rectal cancer. Results: The overall rate of pathological complete response in our study population was 18.75%. Patients homozygous AA for GSTP1 (A313G) presented a rate of pathological complete response of 26.6% as compared to 8.5% of the AG+GG population (p = 0.04). The heterozygous comparison (AA vs. AG) showed a significant difference in the rate of pathological complete response (26.6% vs. 6.8%; p = 0.034). GSTP1 AA+AG patients presented a 5- and 8-year cancer-specific survival longer than GSTP1 GG patients (87.7% and 83.3% vs. 44.4% and 44.4%, respectively) (p = 0.014). Overall survival showed only a trend toward significance in favor of the haplotypes GSTP1 AA+AG. No significant correlations were found for XRCC1 (G28152A). Conclusion: Our results suggest that GSTP1 (A313G) may predict a higher rate of pathological complete response after neoadjuvant radiochemotherapy and a better outcome, and should be considered in a more extensive analysis with the aim of personalization of radiation treatment.

A novel p53-activating radioresponse regulator

  • Jung, Hyun-Ju;Kim, Eun-Hee;Lee, Yun-Sil;Bae, Sang-Woo
    • Proceedings of the Korean Nuclear Society Conference
    • /
    • 2005.05a
    • /
    • pp.1008-1009
    • /
    • 2005
  • In order to screen ionizing radiation induced early-response genes, we employed subtractive hybridization method and isolated a metabolism associated gene. The gene expression was very sensitive to ionizing radiation as revealed by a rapid induction of its messenger RNA. We characterized the function of this gene in radiation response. This gene activated p53 and enhanced cell killing effect of ionizing radiation. This effect was attributable to p53 phosphorylation and transcriptional activation.

  • PDF

Nodal tumor response according to the count of peripheral blood lymphocyte subpopulations during preoperative chemoradiotherapy in locally advanced rectal cancer

  • Heo, Jaesung;Oh, Young-Taek;Noh, O Kyu;Chun, Mison;Park, Jun-Eun;Cho, Sung-Ran
    • Radiation Oncology Journal
    • /
    • v.34 no.4
    • /
    • pp.305-312
    • /
    • 2016
  • Purpose: The objective of this prospective study was to evaluate the relationship between the circulating lymphocyte subpopulation counts during preoperative chemoradiotherapy (CRT) and tumor response in locally advanced rectal cancer. Materials and Methods: From August 2015 to June 2016, 10 patients treated with preoperative CRT followed by surgery were enrolled. Patients received conventional fractionated radiotherapy (50.4 Gy) with fluorouracil-based chemotherapy. Surgical resection was performed at 4 to 8 weeks after the completion of preoperative CRT. The absolute blood lymphocyte subpopulation was obtained prior to and after 4 weeks of CRT. We analyzed the association between a tumor response and change in the lymphocyte subpopulation during CRT. Results: Among 10 patients, 2 (20%) had evidence of pathologic complete response. In 8 patients with clinically node positive, 4 (50%) had nodal tumor response. All lymphocyte subpopulation counts at 4 weeks after CRT were significantly lower than those observed during pretreatment (p < 0.01). A high decrease in natural killer (NK) cell, count during CRT (baseline cell count - cell count at 4 weeks) was associated with node down staging (p = 0.034). Conclusion: Our results suggest that the change of lymphocyte subset to preoperative CRT may be a predictive factor for tumor response in rectal cancer.

Pretreatment of Low Dose Radiation Reduces Radiation-Induced Apoptosis in Mouse Lymphoma (EL4) cells

  • Kim, Jeong-Hee;Hyun, Soo-Jin;Yoon, Moon-Young;Jioon, Young-Hoon;Cho, Chul-Koo;Yoo, Seong-Yul
    • Archives of Pharmacal Research
    • /
    • v.20 no.3
    • /
    • pp.212-217
    • /
    • 1997
  • Induction of an adaptive response to ionizing radiation in mouse lymphoma (EL4) cells was studied by using cell survival fraction and apoptotic nucleosomal DNA fragmentation as biological end points. Cells in early log phase were pre-exposed to low dose of ${\gamma}$-rays (0.01 Gy) 4 or 20 hrs prior to high dose ${\gamma}$-ray (4, 8 and 12 Gy for cell survival fraction analysis; 8 Gy for DNA fragmentation analysis) irradiation. Then cell survival fractions and the extent of DNA fragmentation were measured. Significant adaptive response, increase in cell survival fraction and decrease in the extent of DNA fragmentation were induced when low and high dose .gamma.-ray irradiation time interval was 4 hr. Addition of protein or RNA synthesis inhibitor, cycloheximide or 5,6-dichloro-1-.betha.-d-ribofuranosylbenzimidazole (DRFB), respectively during adaptation period, the period from low dose ${\gamma}$-ray irradiation to high dose ${\gamma}$-ray irradiation, was able to inhibit the induction of adaptive response, which is the reduction of the extent DNA fragmentation in irradiated EL4 cells. These data suggest that the induction of adaptive response to ionizing radiation in EL4 cells required both protein and RNA synthesis.

  • PDF

Response of Radiation Driven Transient Burning of AP and HMX Using Flame Modeling

  • Lee, Changjin;Lee, Jae-Woo
    • Journal of Mechanical Science and Technology
    • /
    • v.15 no.8
    • /
    • pp.1181-1187
    • /
    • 2001
  • The radiation driven response function (R$\_$q/) for AP and HMX propellant was obtained and compared with experimental results by using a simple $\alpha$$\beta$γ flame model rather than with detailed chemistry. For an AP propellant, the profile of heat release was assumed by the experimental data. The calculated R$\_$q/ shows a frequency shift of the peak amplitude to the higher frequency and a decrease in the maximum amplitude as radiation increases. In addition, it was found the increase in the total flux could enhance the mean burning rate γ$\_$b/ while the phase differences between the radiation and resulting conduction could consequently reduce the fluctuating amplitude Δγ$\_$b/. Fortunately, this is the qualitative duplication of the behavior recently observed in the experiments of RDX propellants. For HMX, the response function R$\_$q/ has been calculated and showed a quite good agreement with the experimental data. Even though the fairly good agreement of R$\_$q/ with experimental ones, the unsteady behavior of HMX was not reproduced as the radiation input increased. This is due to lack of the material properties of HMX or the physical understanding of HMX burning at high pressure.

  • PDF

Radiation Therapy for Loco regional Recurrence of Adenocarcinoma of The Rectum (국소재발 직장암의 방사선 치료)

  • Cho K. H.;Seong J. S.;Suh C. O.;Kim G. E.
    • Radiation Oncology Journal
    • /
    • v.2 no.2
    • /
    • pp.237-243
    • /
    • 1984
  • Thirty Patients with loco-regional recurrence following curative surgery for adenocarcinoma of the rectum were retrospectively evaluated to determine factors influencing survival and the efficacy of radiation therapy. In this review of 30 patients undergoing radiation therapy, more than 50 percent(17/30) had definite symptomatic and objective response. Ninety percent of patients(27/30) received significant palliation. Over all 2 year survival rate was $7.4\%$ and their median survival was 13.0 months. Grade of response and Sex were statistically related to survival.

  • PDF

The Calculation of Response Matrix of 2-Dimensional Radiation Monitoring System Using EGS4 Simulation (EGS4 simulation을 이용한 2차원 방사선준위 분포측정 시스템의 Response Matrix 계산)

  • Kim, S.H.;Han, S.H.;Kang, H.D.;Kim, J.C.;Park, I.K.;Choi, Y.S.;Lee, Y.B.;Lee, J.M.
    • Journal of Radiation Protection and Research
    • /
    • v.22 no.2
    • /
    • pp.127-133
    • /
    • 1997
  • In this study an EGS4 simulation code was used to calculate real energy spectrum from measured ${\gamma}$-ray energy spectrum obtained using 2-dimensional radiation monitoring system. As a result, the $39{\times}39$ response matrix was calculated the energy range of 0.1 to 2 MeV which energy interval of 50 keV The real energy spectrum for Co-60 radioisotope was calculated using inverse of response matrix. It was confirmed that the calculated response matrix was useful to the analysis of the measured energy spectrum for the radiation monitoring system.

  • PDF

Combined Radiation Therapy and Hyperthermia in Management of N3(AJCC-UICC) Metastatic Neck Nodes (N3(AJCC-UICC) 전이성 경부 임파절의 방사선 및 온열 병행요법)

  • Lee Chang-Geol;Kim Gwi-Eon;Seong Jin-Sil;Suh Chang-Ok;Loh John-Kyu;Kim Byung-Soo;Park Kyung-Ran;Lee Jong-Young;Hong Won-Pyo;Park Cheong-Soo;Kim Soo-Kon
    • Korean Journal of Head & Neck Oncology
    • /
    • v.8 no.1
    • /
    • pp.37-43
    • /
    • 1992
  • In order to improve the control of large unresectable(>6cm) and fixed N3(TNM-UICC) metastatic neck nodes, local hyperthermia(HT) has been combined with radiation therapty (RT) in Yonsei cancer center. From April 1985 to april 1988, a total of 18 patients of head and neck cancer with metastatic large unresectable and fixed cervical neck nodes who underwent combined RT and HT were analyzed. Of 18 patients, complete response rate was 39% (7 pt.) partial response 39% (7 pt.) and overall response rate was 78%. Acute side effects of these combined modalities were found in 8 patients and which were mainly cutaneous reaction such as erythema, dry and moist desquamation but recovered spontaneously in all patients after treatment. Factors of maximum tumor temperature above $43^{\circ}\C$ and MDF(multiple daily fractionation) showed more favorable response rate but not statistically sinificant. Two year actuarial survival rate of all patients was 35.4%.

  • PDF

Cell-type-specific Gene Expression Patterns in Human Carcinoma Cells followed by Irradiation (방사선에 의한 암세포주 특이적 유전자 발현 양상)

  • Park Ji-Yoon;Kim Jin-Kyu;Chai Young Gyu
    • Korean Journal of Environmental Biology
    • /
    • v.23 no.2 s.58
    • /
    • pp.152-156
    • /
    • 2005
  • Ionizing radiation is a well- known therapy factor for human carcinoma cells. Genotoxic stress mediates cell cycle control, transcription and cellular signaling. In this work, we have used a microarray hybridization approach to characterize the cell type-specific transcriptional response of human carcinoma MCF-7 and HeLa cell line to $\gamma-radiation$, such as 4Gy 4hr. We found that exposure to $\gamma-ray$ alters by at least a $log_2$ factor of 1.0 the expression of known genes. Of the 27 genes affected by irradiation, 11 are down- regulated in MCF-7 cells and 2 genes induced by radiation,15 are repressed in HeLa cells. Many genes were involved in known damage- response pathways for cell cycling, transcription factor and cellular signaling response. However, in MCF-7 cells, we observed gene expression pattern in chromatin, apoptosis, stress, differentiation, cytokine, metabolism, ribosome and calcium. In HeLa cells, it showed clearly the expression changes in adhesion and migration, lysosome, brain, genome instability and translation. These insights reveal new therapy directions for studying the human carcinoma cell response to radiation.